Release Date: 23/11/17 09:14 Summary: Termination of proposed acquisition of West Coast assets Price Sensitive: Yes Download Document 336.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%